References: Primary Withdrawal Study (107 patients): Dick P, Costa C, Fayolle K, Grandjean ME, Khoshbeen A, Tissot R
Suitable for daily leave-in scalp care
GSH plays an important role in the researches process of prevention, recovery and treatment of atherosclerosis, coronary heart disease, anti-aging, anti-tumor, prevention, prevention of Alzheimer's disease and other diseases
Moreover, the United States Food and Drug Administration (FDA) has not approved DSIP (Delta-Sleep-Inducing Peptide) for any therapeutic application
No negative interactions - Vitamin D: No direct peptide interactions, but low vitamin D impairs healing, which can reduce the effectiveness of BPC-157 and TB-500 protocols
Our mission is to empower you with the tools and education needed to take control of your health journey